Overview
POM market data
Price History
POM price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for POM. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
POMDOCTOR Regains Nasdaq ComplianceBenzinga · Jul 13, 2026, 12:07 PM
POMDOCTOR Announces Strategic Upgrade, Positioning As Infrastructure Provider For Predictive Healthcare Data And ServicesBenzinga · Jul 2, 2026, 12:10 PM
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News PendingBenzinga · Jun 18, 2026, 11:55 PM
POMDOCTOR Plans To Change Ratio Of Adss To Class A Ordinary Shares From Current Ratio Of One ADS Representing One-Sixth Class A Ordinary Share To New Ratio Of One ADS Representing Three Class A Ordinary SharesBenzinga · May 28, 2026, 12:25 PM
Pomdoctor FY EPS $(3.14), Sales $57.187MBenzinga · May 14, 2026, 8:53 PM
Small Chinese Firms Withdraw Wall Street IPO ApplicationsBenzinga · May 14, 2026, 4:15 PM
Dow Edges Higher; Mosaic Shares Fall After Q1 ResultsBenzinga · May 11, 2026, 3:40 PM